Janice Besch - National Institute of Complementary Medicine (NICM) - Rise of alternative therapies in PHI policies


Published on

Janice Besch delivered the presentation at the 2014 Health Insurance Summit.

The 2014 Health Insurance Summit focused on how legislative changes affect the future of health insurance in funding, membership and services.

For more information about the event, please visit: http://bit.ly/HISummit14

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Janice Besch - National Institute of Complementary Medicine (NICM) - Rise of alternative therapies in PHI policies

  1. 1. Rise of Alternative Therapies Push towards preventative health
  2. 2. Alternative Therapies? • Customary • Traditional • Alternative • Complementary • Natural • Integrative • ‘Not medicine’
  3. 3. Characteristics • Multiple additional interventions – Medicine, lifestyle, manual therapies • Tailored to individual needs – person centred • Multiple end points – Symptom relief – Reducing disease severity – Delaying disease progression – Disease prevention – Improving quality of life
  4. 4. The Australian Landscape • $3.5Mpa industry • 2/3 Australians regular users • Includes all nutritional supplements, herbal medicines, acupuncture, mind-body therapies, manipulative therapies • National Registration Boards for osteopathy, chiropractic, Chinese medicine • Ageing population, chronic disease, economic burden
  5. 5. A Growing Sector • The workforce is growing – up 80% between 1996 and 2006 compared with population growth at 12% and health professionals overall at 31% • The number of people consulting practitioners is growing – Almost doubling over the same time period Source: ABS Complementary Therapies Report 2008
  6. 6. Trend to Integrative Care • 30% - 40% of GPs subscribe, administer and use CM • 59% report increasing patient demand • 93% of Victorian GPs reported referring to a CM practitioner at least once • 62% of GPs surveyed in WA wanted more training • 85% of pharmacists also looked for more training and information on CM • The Australian Medical Association, the Australian Medical Council and the Australian College of Nursing support further training and information as well as responsible use of CM
  7. 7. CM Users: A Healthy Profile • Seeking to manage chronic disease, improve well- being and pursue a preventative healthcare approach • Exhibit healthier lifestyles, with more exercise, less smoking and better diets • 73% eat at least minimum daily serves of fruit and vegetables, compared to 54% of the general population • 42% take CM to address national priority health conditions
  8. 8. Clinical Effectiveness of CM • The knowledge base for all forms of health intervention is constantly evolving • Multiple dimensions – Clinical trials – Observation – History of use • NICM’s work to establish national research priorities for CM provides guidance
  9. 9. About NICM • Approx 50 academic, professional, HDR students and $3.5-4Mpa • Bench to bedside capabilities 1. Preclinical studies 2. Clinical trials 3. Research translation and policy Australia’s only ERA 5 ranked CM Institute – work ‘well above world class’
  10. 10. NICM: HISTORY AND GOVERNANCE • Operating as a UWS research centre since 2000 • NICM established 2007 by Commonwealth and State Governments as independent agency ($4.6M) • Hosted and oversighted by UWS • Diverse funding base • Now entering a significant expansionary phase
  11. 11. Where to from here? • Research – the current evidence base is incomplete, and the assessment of complex herbal medicines and multi-component management plans is difficult. • Evaluation – an agreed method for certifying and supporting safe and efficacious CM use through the private healthcare system
  12. 12. Cost Effectiveness Frost & Sullivan [US] “..the use of key dietary supplement ingredients can reduce illness-related hospital utilization costs associated with heart disease, age-related eye disease, diabetes and bone disease in the United States…” Access Economics [Aus] “Four of the five CMs assessed were found to be cost-effective as alternative or adjunctive treatments for national health priority areas…”
  13. 13. NHMRC funding for CM research 13
  14. 14. The NICM Team